<SEC-DOCUMENT>0001437749-12-004645.txt : 20120508
<SEC-HEADER>0001437749-12-004645.hdr.sgml : 20120508
<ACCEPTANCE-DATETIME>20120508162228
ACCESSION NUMBER:		0001437749-12-004645
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20120508
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120508
DATE AS OF CHANGE:		20120508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		12821713

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>biokey_8k-050812.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
    <title>biokey_8k-050812.htm</title>
    <!--Licensed to: EdgarEdge-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt">Washington, D.C. 20549</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">CURRENT REPORT</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date of Report (Date of earliest event reported): May 8, 2012</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="3" valign="top" width="80%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">BIO-key International, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr></table>

<div>&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of incorporation)</font></div>
</td>
<td valign="top" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1-13463</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Commission File Number)</font></div>
</td>
<td valign="top" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">41-1741861</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="3" valign="top" width="80%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3349 Highway 138, Building D, Suite B</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Wall, NJ 07719</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(732)&#160;359-1100</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="FONT-STYLE: italic; DISPLAY: inline">see</font> General Instruction A.2 below):</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 2.02.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 8, 2012, BIO-key International, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for its first quarter 2012, which is included as an exhibit to a Current Report on Form 8-K.&#160;A copy of the press release issued by the Company on May 8, 2012 is attached as Exhibit&#160;99.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements, Pro Forma Financial Information and Exhibit.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press Release, dated May 8, 2012, issued by <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">the Company.</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-WEIGHT: bold"> </font>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">BIO-KEY INTERNATIONAL, INC.</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date: May 8, 2012</font></font></div>
</div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cecilia C. Welch</font></font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cecilia C. Welch</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>
</div>

<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>

<div align="center">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 40px">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 101px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit No.</font></font></div>
</td>
<td width="1096">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 40px">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 101px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">99.1</font></div>
</td>
<td width="1096">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Press Release, dated <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">May 8, 2012, issued by </font>the Company.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
    <!--Licensed to: EdgarEdge-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 99.1</font></div>



<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td rowspan="2" width="60%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><img src="biokeylogo.jpg" alt=""></font></td>
<td colspan="2" width="40%" style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold">NEWS RELEASE</font></font></td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contacts:&#160;&#160; </font></td>
<td valign="top" width="31%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">BIO-key International, Inc.</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Scott Mahnken</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">732-359-1113</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">BIO-key&#174; International, Inc.</font></div>

<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">Reports Profitable 2012 First Quarter Financial Results</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net income increased 51% over first quarter 2011</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Wall, NJ, May 8, 2012</font> &#8211; BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions, today reported financial results for the first quarter ended March 31, 2012.&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total revenue for the three months ended March 31, 2012 was approximately $1.4 million, which was equal to the $1.4 million reported for the quarter ended March 31, 2011.&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key&#8217;s gross margin for the first quarter of 2012 was 87% compared to 92% for the same period in 2011.&#160; Operating expenses for the first quarter of 2012 decreased 15% to approximately $859,371 compared to $1,006,253 in the comparable quarter ended March 31, 2011.&#160;Operating income for the first quarter of 2012 was $369,626 compared to $283,988 reported in the quarter ended March 31, 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net income for the first quarter of 2012 was $363,498, a 51% improvement over the net income of approximately $240,071 for the comparable quarter in 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;We are pleased with our performance in the first quarter and the progress we have made to once again get the company to profitability.&#160;&#160;We closely managed our expenses while continuing to invest in core technology as well as expanding our sales footprint. We hired two new Sales Directors in the first quarter to continue to generate revenue through our partner network,&#8221; said Michael DePasquale, BIO-key&#8217;s Chief Executive Officer.&#160;&#160;&#8220;Additionally, we continue to see increased demand for fingerprint biometrics from our domestic and international customers and channel partners as the speed of adoption is beginning to intensify.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Liquidity and Capital Resources</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consolidated cash, cash equivalents and accounts receivables totaled over $698,000 on March 31, 2012 compared to $631,000 as of December 31, 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Highlights for the first quarter included the following:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The company reported record profitability for the quarter; the increase can be attributed to modified sales strategies and operational efficiencies.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Awarded a contract to provide fingerprint technology for the Provincial Government of British Columbia Department of Corrections.&#160;&#160;The solution will be utilized by inmates and staff to access and track various applications including inmate records and personal services.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Secured agreement to provide biometric technology to a large blood center serving over 1 million donors.&#160;&#160;BIO-key now&#160;&#160;supports&#160;&#160;four of the largest independent blood centers in the U.S.&#160;&#160;with our TruDonor ID solution</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Purchase orders for&#160;&#160;product rollouts from MedFlow, Robinson Memorial Hospital, LexisNexis, Identimetrics, Solfed, Team Praxis and Union Pacific</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Attended the IBM Pulse Event March 4-7</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="DISPLAY: inline; FONT-SIZE: 10pt"> 2012.&#160;&#160;Pulse&#160;&#160;is the largest annual gathering of IBM resellers in the United States</font></font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Attended HIMSS Conference Feb 20-24<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> 2012.&#160;&#160;The Health Information Management Systems Society is dedicated to promoting a better understanding of health<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">care</font> information&#160;&#160;technology<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> in the health care industry.</font></font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About BIO-key</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&#160;BIO-key&#8217;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#8217;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&#160;&#160;BIO-key&#8217;s technology is offered directly or by market leading partners around the world. (<font style="DISPLAY: inline; FONT-WEIGHT: bold">http://www.bio-key.com</font>)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BIO-key Safe Harbor Statement</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain statements contained in this press release may be construed as &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;).&#160; The words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes&#8221; and similar expressions are intended to identify forward-looking statements.&#160; Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#8220;safe-harbor&#8221; provisions of the Act.&#160; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&#160; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel.&#160; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission.&#160; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&#160; The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#169;<font style="DISPLAY: inline; FONT-SIZE: 10pt"> Copyright 2012 by BIO-key International, Inc.</font></font></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>biokeylogo.jpg
<TEXT>
begin 644 biokeylogo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@`!`3$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,`#@H+#0L)
M#@T,#1`/#A$6)!<6%!06+"`A&B0T+C<V,RXR,CI!4T8Z/4X^,C)(8DE.5EA=
M7ETX169M95IL4UM=6?_;`$,!#Q`0%A,6*A<7*ED[,CM965E965E965E965E9
M65E965E965E965E965E965E965E965E965E965E965E965E96?_``!$(`)<`
MR@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/1J***0@HHHH`**R]4UZQTL%9I=TO:).6_^M^-<AJ/C"_N25M@M
MK'_L\M^=1*I&)T4L-4J:I:'?3W$-LF^>:.)?5V`K(N?%>DP9`G:8CM&I/Z]*
M\XFFEG<O-(\CG^)V)-)'&\KA(D9V/15&36+KOHCNC@(K6;.VE\<VX_U-G*W^
M\P7_`!JL?'4F?EL$Q[R'_"LBV\,:M<X(MO*4]Y6"_IUK3B\#W3#][=PI_NJ6
M_P`*7-58W3PD-R0>.I>]BG_?P_X5/%XZC/\`K;%U_P!V0'^@I%\"I_%?L?I%
M_P#7H?P*F/DOV'UCS_6J_>F;>#?],T;?QAI4Q`=I83_MI_AFM>UO[2\&;:XB
ME]E8$_E7&R^![I0?*NX7_P!Y2O\`C6;/X9U>T.];<OMZ-"V3_C3YYK=$NAAY
M_!.QZ;17F]GXEU739/+N"TJCK'.#N'X]:Z[2?$MCJ6(]WD3G_EG(>OT/>KC4
MC(YZN%J4]=T;5%%%:',%%%%`!1110`4444`%%%%`!114%W=0V=L\]PX2-!DD
MT`E?1#YYH[>%I9G5(U&2S'`%</K?BZ6X+0:<3%%T,O\`$WT]/YUEZ[KD^KSD
M',=LI^2//ZGWK(KEJ56](GKX?!J/O5-Q6)8DL22>23WJS8V%SJ$WE6L+2-WQ
MT'U/:MG0/#$NI;;BZW0VO;^\_P!/0>]=[:6EO90"&VB6.,=@/Y^M*%)RU9=?
M&1I^[#5G,Z9X+AC`?4)3*W_/-#A?SZG]*Z:VL[>T39;01Q+Z*N*GHKIC!1V/
M*J5IU/B844451D%%%07-Y;VB;[F>.)?5V`S0-)O1$]%8$_B_28B0LDDI_P!A
M#_7%5O\`A-]/S_J+G'KM7_&I]I'N;+#U7]EG0W5G;7D>RY@CE7_:7.*Y?5/!
M<;9DTV4QMU\N0Y'X'J*TK?Q;I,Q`,SQ$_P#/1"/U%;$%Q#<QAX)4E0]T8$4F
MH3'&5:AW1QFFZ_?:-<"RUB.0QC@,W+*/7/\`$*[2&:.XA66%U>-QE64Y!J&_
MT^VU&W,-U$'7L>ZGU![5RB?;/"-X`Y:?2Y6Z_P!T_P!#_.EK#?8MJ%?6*M+M
MW.UHID,J3Q)+$P='&58="*?6AR!1110`4444`%%%%`"$A023@#DFO-O$VMMJ
MEX8XF(M(CA!_>/\`>_PKH_&FJ&UL5LXFQ+<#YL=D[_GT_.O/ZYJT_LH]7`T-
M/:2^05U/A7P[]M*WMXO^CJ?D0_\`+0^I]OYUE^'M*.K:BL39$"?-*1Z>GXUZ
MA&BQ1JB*%11@`=`*5*G?5EXS$<BY([B@```#`'84M%%=1XX4444`%-=E1"SL
M%51DD]!3JYGQK]N>QBBM8W>%B?-V#)]AQVI2=E<NG#GDHWL9^M^,'+M!IF%4
M<&8CD_0?UJCI_AS4=787-Y(\4;<[Y<EV^@K3\*^&]@%[J$7S]8XG'3W(KL:Q
MC!SUF=M2O&C[E%?,PK/PGI=L!OB:X;UE.?T'%:2:981C"65NH]HE_P`*MT5L
MHI;(XY59RW91ET?39AB2QMS[B,`_I69)X7B@D\[2KF:RF'HVY3]0:Z&BAQ3"
M-6<=F8UEJ=Q#<+9:M&L4[<1RK_JY?IZ'VK4N((KJ!X9D#QN,,I[TV\M(;VW:
M"=-R-^8/J/0U7TR651)9W+;YH,8<_P#+1#T;Z\$'W%"TT8.S]Z.C,C2C)H6J
M?V5.Q:TG):VD;L>Z_P"?ZUTU9VMZ>-1T]HU^6=/GB?NKCI4FD7GV_389V&)"
M-LB^C#@C\Z4=-"JCYUS]>I=HHHJC$****`"BBB@#RG7KXZAJ]Q-G*!MB?[HX
M'^/XUG5N:IX:U"SN7$,#SPDY1XQGCW'K4VB^%[N[N5>\A:"V4Y;>,,WL!7"X
MR<MCZ"-:E"FFGH33WEYX5\*07-I:>;/=-ODE925B&/ESCV_K7)Q:]XDUZ_CM
M8;^<S3'"I&WECU[8KU'Q:`OA/4@!@"`X%>7_``^_Y'&R^DG_`*`U=T596/"G
M-SDY/J:-_HWB_1[9KUKZ>1(QN<Q7+,5'J0:U_!?C:>]O(].U4J\DG$4P&"3Z
M-_C7::S<P6FD7<URRK$(FSN[\=/QKQ7PM;2W7B73TA!+"=7..P!R3^0IDG6>
M-;OQ)HU\;@:F5M+B1A"L9QM`[$8J/P;>>)=;OQ*NIDVUNZF82G.X'L!CT!K0
M^+'_`!X:=_UU?^0J/X3']QJG^]'_`":@#J?$WB2U\/6@>4>9<29\J$'!;W/H
M*\]C\1>*O$ETT.GNZCJ4MP$"#W8_XUB^*=4?5]?NK@L3&'*1#T0'`_Q_&O7O
M"NDQZ/H5M"J`2NHDE;N6(Y_+I0!Y_<Z-XUL$-S]HNY,<MY=R7(_#/-6?#WQ"
MNH9TM]:Q+"3CS@N'3Z@=1^M>H5Y)\2M)CL=9BNX$")=J2P`XWCJ?QR/UH`]9
MCD26-9(V#(P!5@<@BG5Q/PRU1KO1YK*5BSVC#:3_`'&S@?@0:[:@14U2>YMM
M.GFL[?[3<(N4BSC<:\G/BS7;G7K=;BY>#;.JM`@V*/FP01W_`!KV.O#=0_Y'
MBX_["!_]&4`>Y57EB/VR"9!R`R-_ND9_F!^=3-(BG#.H/N:%=6^ZP;Z&D-.P
MZLNP3[+JU];CB.7;<(/<\-^HS^-:3ND:%W944=2QP!6<MW:3ZK`]O=V\C"-T
M94E4GDJ1QGV-)CB]T:=%-9U7[S!?J:02(QP'4GT!IDCZ*:SJOWF4?4T*ZL"5
M8''7!H`=13(Y$E7=&ZN.F5.:?0`4444`8WB[_D5=3_ZX-7D_@R*>?Q%%%:R^
M3.\4HCD_NMY;8->L>+O^15U/_K@U>7_#P_\`%8V?^[)_Z`:8RQKGA3Q-';M<
M7DC7L<?)*S%RH]<'FI_A_KVGZ9=_9KJV1)9SM%WG)&>BGT'N/QKUD\CFOGW5
MD2+6;U(<>6D[A,>@8XH`]#^+'_'AIW_75_Y"JWPO)&G:T5^\`F/R:D^(K._A
MW0VESYC#+9]=@S4OPG`-OJH/0M'_`":@#SF`!KF,-T+C/YU]%#H,5X#KE@^E
MZU=VC`CRI"%]UZ@_EBO;M!U!-4T6TNT(/F1C=[,."/SS0!HUP'Q7`_LW3S_%
MYS`?3'_ZJ[^O+/BEJ*3ZE;6,;`_9D+/CLS8X_(#\Z!"_"IMNI:ADX3R`23T^
M]_\`KKTK[;:XS]IAP?\`IH*\[\$>'Y;WPMJKA_*:^7RHF/HO4_0DX_"JW_"L
MM4_Y_;/\V_PH&>GI=6\CA8YXG8]`K@FO$]0_Y'BX_P"P@?\`T976:%\/[_3=
M9M+R:\MS'"X<B/=DX[=*XS6T>7Q7?QQ<2/>.J\XY+G%`&YXU@@U;Q?\`9]),
MMQ=R$)*-V4#`8P/3`'-=IX<\,6OA:":]EN7DE\D^:QX10.3@?A7GGAS4Y/"_
MB1C>PXP3#.&&649Y(_SS7J/B>03^$=0EMG#J]L65E.05QU_*@#S*^U+4/&GB
M"*U5RD4CXBBS\J+ZGU..:O>+/!UOX?TR&\@O7>3>$97`!8^JXK&\)WEQ8:I)
M<6=O]HNE@?RH\9R>,G'?`R:Z6R\*:UXEN5OO$%Q)!$>B-]_'H%Z*/\XH`Q[.
MUNO%&C7D\TTTMYID2^62<B1.25/N,'FH_`=I:WGB6!+J62-D_>1;#C<R\X/X
M9KUW2]*L])M!;64*QQ]3W+'U)[UY!XALY?#/BUFMAL5)!/`>VTG./YB@#I_B
MCI]JL4&H-+(+IR(ECS\I49)..W_UZL>&O"[Z?H(O,RO<W2*TD/8)G(&.YZ$_
MB*R;Z[7QIXRT^"')LHD5F![#[S_T7\*]1RJ@#@`4`8FAV\T<Y9@^T*0[E64/
M]W:,-SQAOS_`;M(#GI2TA!1110!ROCZ+5Y]'$6EQF2)\BX5%RY7MCVZ].:\L
MTJ]N=`UB&\\@B6$G]W(",@C!'Y&O?:CDABE&)8T<>C*#3`\RO_B5=7-JT-G8
M+;RN-OF&3>5^@P.:S_"W@Z]U:]CN+Z%X+%3N8R`@R>P'OZUW7_"0Z1::,FK+
M9&.!YS!\L2A@<D9X[<5K-J]O_:-K9H&D:YA::-UP5*C_`/70,\Y^(6KR:C=K
MIR6,L2V4C#>P^_VX&.E,^'VKRZ5?O9M8S2B]D1=Z@_)C(SC'3G]*[7_A+5^V
M_9/[&U3[1L\SR_*7.W.,_>Z9JQ>>(TMM3DL(M.OKJ:-%=O(12`#T[T`4/&?A
M)=>C%S:E4OHUP-W`D'H??T-<'INJZYX-N'AD@=(V.6AF4[6/J#_45Z=>>(4L
MM-M[R>QO%:XE$*P;!YFXYQQGVI+'7;;4;XZ?<65S:W!3S%CNH@-Z^HY-`'#7
MGQ*U">`QVEG%;R,,;]Q<CZ#_`/75#0?"&IZ]>?:;X2P6SMNDFE&&D]<`]?KT
MKO[#7='ET^_OK:U"?82WFH(U#\=QCUYK3O-8M[+1?[4F#^3L5PH`W'=C`^O-
M`%NUMH;.UBMK=`D,2A54=@*FK*36XY]%AU*TMKFZ27&(HE!<=CD9[8JMI/B5
M-6E*PZ=?1QJ65I9$`12O4$@]:!&EJM\--TV>\,4DPA7=LC&2:\.N+B6;7)-1
M%M(`]P9]F#_>SC->Q+XFL3H,6K,LJPS,4CCVY=VR1@`=^*6P\0P75^EE<6EU
M8W,BEHTN$"^8!UP0>OM0!R?BC2?^$FT2'Q!8VLD-R%/F0L/F=0<9]R,?B*S_
M``;XCGM(AH]]9SW-K.VQ-H.4#<$8[CG^==[9^(K*[GU*",2++IY;S$8#+`9R
M5YY'%6(]7MFT(:N0R6YA\[#`;L8Z?6@9Y7JV@ZIX3UA;RU5W@C??%.JY`'HW
MIZ>];!^)=Y+`(H-,3[4PP&WEAGV7&?UKO-'U>VUG31>VX<1DLK(X&Y2.H-&C
M7=IJ=A'?VD'EI+G&Y`&X)';Z4`8/@BSUL276HZS/,/M(&R&0\CGKC^'TQ5;X
MGZ;'/HT5^"JRVSA>?XE;C'YX/YUW%>3^.M;?7=9ATJP.^"*38,=))#QGZ#I^
M=`B_\/K=-+T2_P!=N%R6'EQCU`Z_FV!^%9FH:A<ZC<--<RLQ)X7/"^P%;WB:
M2/3=+L=#MR,0H&D([_\`ZSDURU<E:5W8]C`T4H\[6K-WPKJ-S;ZO;P+(QAF;
M8R$Y'UKTJO/_``18?:-2>[<?);CCW8__`%LUZ!6M&_+J<F.<?:V04445J<04
M444`>>0V,TGA'3K>6VD;.J@O&R'[F]LDCTQ5G2-.O=-\9V]G(CO96T,OV>8@
MD;&((4GU!R*[JBF!SIAD_P"%@B;RW\K^S=N_:=N?,Z9]:Q=8CC3QA>RW3:K#
M"T$81[$/\Q[@D"MW6M0O=(OXKHDRZ:_RR(%&4/KFMJWGBNH$F@</&XR&'>I4
MDW8MP:2ET9Q^LQ?;]#T:.S;4&07Z`RRJWG*/FRQR.WJ:FTBRFTWQ=*FH&YO6
MDB_T6\D);:O=#V!]_P#&NJN(VE@=$E:)B.'7&5_.L![W6M()%W;C4;<=)HAA
MP/<4.5APAS[/4Y.71[V#PY+?V4$GGR&>WN8=IS)&SG:V/4''X5N:I%J%^-!T
MVSA4^3$EU*9PPCRH`520/7/%:D/B_2I/]8TL+=PZ'C\LU,?%.C@9^UY^D;?X
M4N>/<IT:B^RS.\)I?:;J.H:7?0JJLWVF%H@QC&X_,H)]#CCZU/X0ADBTB^66
M-T8W<Q`92"03P:9<^-;",$6\4TS=N-H_7_"L23Q!K>JW`6Q5XQV2%<_F3_\`
M6J75BMC2.$J2U:LO,+2QO(O">@W2VLLC6%TTTL`7YRN]N0/6M.6Z/B'Q#I+V
M5M<);V+M+--+$4`R,!1GJ:T-&T_5U=9M3U"0XY$*D'\SC^5;]6G<PG%1=D[G
MG4VDWBQ:QJEE"XO(;Z<;"I_?0L`"/?U%6+F"^NO"N@Z-;0$2W"JTWFJP553G
M#$#C)Q^5=[15$'(:%%J.F>(+^VOH8Q'?I]H0VX8QJXX(R1P3UJ+PAK$5AHMI
MI]S;7J7`=E/^C/M&7..<>]=I10`UU#HR-T88-<B_AS0O#+?VJJ2M+%_JE>3(
M+'I@5T]]>P6%LT]RX1%_,GT'O7FFMZO-J]WYC_+$O$<>?NC_`!K*I4Y5YG5A
ML.ZLM=BE=7,EW<R7$S;I)&W$U'&C2R+'&I9V.%`[FFUV_@_03$%U&[3#D?N4
M/8?WJY8Q<V>O6JQHPN;^A::NEZ9'!P9#\TA'=CU_PK1HHKN2LK'@2DY-MA11
M102%%%%`!1110!'/!'<P/#,@>-QAE/>N,D%]X1O"T8:XTV1NA[?X'^==O3)H
MHYXFBE17C88*L,@U,HWVW-:57DT:NGT*NFZI:ZG`)+60-_>4\,OU%7:XC5/#
M-WITYO-&DD(7G8I^=?IZC_/-+IWC.2(^5J<!8C@R(,-^(J54MI(V>&YUS4G=
M?B=9<Z=97?-Q:PR'U9!G\ZHMX8T=CG[&H^CL/ZU:LM7L+\#[/<QLQ_@)PWY&
MKU5:+U,.:I#2[1F1>']*A.5L82?]H;OYUH1QI$H6-%11T"C`I]%4DEL2YREN
MPHHHH)"BD9E5268*!W)K'O\`Q-IED"//\YQ_#%\WZ]*3:6Y482F[15S9K(UC
MQ!9Z4I5F\VXQQ$IY_'TKDM4\77MX"EL/LL1_NG+G\>WX5SK$L2S$DGDD]ZPG
M6_E/0HX!O6I]Q=U35;K5;CS;E^!]U!]U?I5&K-C87.H3"*UA:1N^.@^I[5W6
MA>%8+`K/=[9[D<@?PI]/4^]91A*;N=M2M3H1M^!F>&?##2,EYJ"80<QPMW]S
M[>U=L.*6BNN,5%61XM6M*K+FD%%%%49!1110`4444`%%%%`!1110`5F:IH5C
MJ@)GBVR]I4X;_P"O^-:=%#2>C*C)Q=XL\^U#P;?6Y+6CK<IV'W6'X=*S1?:Q
MI;!&FNH,=%DSC\CQ7J=->-)%*R(KJ>S#(K%T5]EV.R.-E:U17/.8O%^K)]Z2
M*3_>C'],58'C;4>\-L?^`M_C763^'M*N"2]E&I/=,K_*J,G@W2F.5\]/]V3_
M`!!I<E1;,T5?#/>!@/XUU(CY8K9??:?\:J3>*=7F&/M(C'^P@%=-_P`(3IO_
M`#UNO^^U_P#B:4>"M,'62Z/_``,?X5/)5[EJMA5M'\#A+B\N;HYN+B67_?<F
MH>IQ7I,/A/2(SDP/(?\`;D/]*TK;3;*T_P"/>UAC/JJ#/YT>QD]V4\?3CI&)
MYM9:%J5\1Y-JX0_QN-H_6NFT[P5%&0^H3&4_\\X^%_/J?TKKJ*TC1BCDJ8VI
M/1:$-M;06L0BMXDB0=E&*FHHK4XV[[A1110`4444`%%%%`!1110`4444`%%%
H%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
